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ABSTRACT 
Necrotic enteritis (NE) is caused by type A strains of the bacterium Clostridium 
perfringens, leading to an estimated 2 billion dollar global economic loss in the poultry 
industry annually. Traditionally, NE has been effectively controlled by antibiotics added 
to the diet of poultry. Concerns about increasing antibiotic resistance of poultry and 
human based pathogens have led to the consideration of alternative approaches for 
controlling disease, such as vaccination. NE causing strains of C. perfringens produce 
two major toxins, -toxin and NetB. Immune responses against either toxin can provide 
partial protection against NE. We have developed a fusion protein combining a non-toxic 
carboxy-terminal domain of the -toxin (PlcC) and an attenuated, mutant form of NetB 
(NetB-W262A) for use as a vaccine antigen to immunize poultry against NE. We utilized 
a DNA sequence that was codon-optimized for Nicotiana benthamiana to enable high 
levels of expression. The 6-His tagged PlcC-NetB fusion protein was synthesized in N. 
benthamiana using a geminiviral replicon transient expression system. The fusion 
protein was purified by metal affinity chromatography and used to immunize broiler 
birds. Immunized birds produced a strong serum IgY response against both the plant 
produced PlcC-NetB protein and against bacterially produced His-PlcC and His-NetB. 
However, the PlcC-NetB fusion had antibody titers four times that of the bacterially 
produced toxoids alone. Immunized birds were significantly protected against a 
subsequent in-feed challenge with virulent C. perfringens when treated with the fusion 
protein. These results indicate that a plant-produced PlcC-NetB is a promising vaccine 
candidate for controlling NE in poultry. 
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INTRODUCTION 
The Burden of Antibiotic Use 
Since the 1940s the inconvenience of disease in livestock of all types was, and in 
many places is, controlled via the use of antibiotics (Gustafson and Bowen, 1997; Price et 
al., 2015). Antibiotics and the poultry industry have enjoyed an intimate relationship 
since the discovery that antibiotics reduce the amount of feed needed to bring broilers to 
market weight (Gustafson and Bowen, 1997). However, just as concerns arose in the 
medical industry about overuse of antibiotics in humans the same concerns arose in 
agricultural sectors (Sneeringer et al., 2017; Witte, 1998). Antibiotic resistance has been 
a topic of discussion for decades and, although antibiotics are still used regularly, there 
has been a notable decline in said use, especially in European countries (Butaye et al., 
2003; Levy, 2014). 
A decline in antibiotic use presents its own issues since many major diseases, 
such as salmonellosis, bovine tuberculosis, brucellosis, and necrotic enteritis were 
controlled by antibiotics (Immerseel et al., 2004; Wiethoelter et al., 2015). As antibiotics 
can no longer be used as a long-term control method for disease another avenue must be 
perused, the most logical being vaccination. However, there are many challenges 
associated with vaccination of livestock such as vaccine cost, vaccine administration, 
vaccine coverage, and farmer compliance (McReynolds et al., 2004a).  
Poultry may very well be the most difficult of livestock to vaccinate as there are 
the most animals to vaccinate paired with the fact that broilers go to market between 5-7 
weeks after hatching. Meat consumption is increasing worldwide with poultry as a 
growing source of animal protein, leading to an increased number of broiler birds in 
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need of vaccination yearly (Sans and Combris, 2015). Poultry is also accountable for 25% 
of foodborne illness outbreaks in the United States, reinforcing the need for vaccines 
against common poultry diseases (Chai et al., 2017). Clostridium perfringens is a 
ubiquitous disease-causing bacteria in poultry, accounting not only for 26% of poultry 
based foodborne illness, but also resulting in economic losses of 2 billion dollars 
annually in the poultry industry (Chai et al., 2017; McReynolds et al., 2004b; Van der 
Sluis, 2000). C. perfringens causes necrotic enteritis (NE), necrosis of the intestinal 
mucosa, leading to decreased weight or death of broiler birds (Rood et al., 2016; Rood 
and Cole, 1991; Uzal et al., 2015). NE generally occurs in broiler birds at 2-6 weeks of age 
but can also occur in older birds (Cooper et al., 2013; Cooper and Songer, 2010). This 
timeline of disease is important to note since broilers go to market as early as 5 weeks 
post hatch and their immune systems are not wholly developed at 2 weeks of age. Since 
this is the case any vaccine given to chickens must be done as early as possible, while still 
being effective with minimal boosts. 
C. perfringens Toxins as a Path to Vaccination 
To combat a disease its pathology must be understood to elicit antigenic targets 
for vaccination. However, NE pathogenesis is complex due to interactions of many C. 
perfringens genes paired with reduced intestinal health caused by food type, mycotoxins, 
environmental factors, and the presence of other pathogens (Prescott et al., 2016; 
Shivaramaiah et al., 2011). Toxins implicated in broad clostridium infections include; 
alpha toxin (CPA), beta toxin (CPB), epsilon toxin (ETX), iota toxin (ITX), enterotoxin 
(CPE), and necrotic B-like toxins (NetB) (Navarro et al., 2018). Luckily, two toxins have 
been identified as favorable targets for vaccination in poultry; -toxin and NetB.  
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-toxin is encoded by the plc gene and is the major virulence factor for gas 
gangrene in humans (Navarro et al., 2018; Titball et al., 1999). The toxin is divided into 
two domains; the amino-terminal domain (encoding the catalytic site of phospholipase 
activity) and carboxy-terminal domain (encoding the sites involved in interactions with 
phospholipids which target the toxin to host cell membranes) (Guillouard et al., 1996, 
1997; Naylor et al., 1998; Titball et al., 1991). A nontoxic carboxy-terminal fragment of 
the -toxin (aa 247-370), dubbed PlcC, has been shown to confer protection against C. 
perfringens when used as a vaccine target in a gas gangrene mouse model as well as 
induce neutralizing antibodies in rabbits (Siqueira et al., 2018a; Williamson and Titball, 
1993). Vaccination against C. perfringens infection using PlcC, delivered as purified 
protein or via live attenuated bacteria, has proven effective in protecting chickens against 
intestinal lesion challenge with pathogenic C. perfringens (Jiang et al., 2015; Kulkarni et 
al.; Nagahama et al., 2013; Siqueira et al., 2018b; Zekarias et al.). The only commercially 
available vaccine for NE is based on an -toxin derived from a specific A strain of C. 
perfringens, given that it is one of many causative factors for NE (such as NetB) an 
improved vaccine approach is desirable (Crouch et al., 2010). 
NetB is a -like, pore-forming toxin and virulence factor in C. perfringens 
mediated NE (Rood et al., 2016). The NetB toxin gene is located on large conjugative 
plasmids similarly related to other toxin carrying plasmids and is transcribed as a 
monomer that forms heptameric pores (Keyburn et al., 2010; Rood et al., 2016). NetB 
was identified in C. perfringens type A strains which were parthenogenic and not 
generally found in healthy birds (Keyburn et al., 2008; Rood et al., 2016). Both purified 
native NetB and recombinant NetB exhibited cytotoxic activity against chicken leghorn 
male hepatoma cells (LMH) inducing lysis (Keyburn et al., 2008). Given its importance 
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in the pathology of NE, NetB has become an antigen of interest concerning C. 
perfringens vaccination. NetB functions by binding cholesterol in membranes, forming 
heptameric pores of at least 1.6 nm (Savva et al., 2013; Yan et al., 2013). To attenuate the 
toxin for vaccination purposes several single amino acid substitutions in the rim loop 
region of NetB, believed to interact with the host membrane, have been identified to 
significantly reduce toxicity. Single amino acid substitutions include; Y191A, R200A, 
W257A W262A S254L, R230Q and W287R (Savva et al., 2013; Yan et al., 2013). NetB, 
like the -toxin or PlcC portion of the -toxin, has been used successfully to protect 
broiler birds against C. perfringens challenge (Fernandes da Costa et al., 2013; Keyburn 
et al., 2013; Yan et al., 2013). Non-toxic rim mutants, W262A and S254L, have also been 
shown to generate a protective immune response in broiler birds (Fernandes da Costa et 
al., 2013; Keyburn et al., 2013). 
In a recent study that examined serum antibody levels against C. perfringens -
toxin and NetB toxin of commercial birds involved in field outbreaks of NE, it was found 
that serum antibody levels against both -toxin and NetB toxin were significantly higher 
in healthy birds compared with those showing clinical signs of NE (Lee et al., 2012). 
Higher antibody titers against these toxins in healthy birds indicate that they play a key 
role in NE. These field results, paired with the clinical studies showing that vaccination 
with either -toxin, PlcC, NetB toxin, or NetB rim domain mutants make a vaccine 
utilizing both toxins, preferably their non-toxic variants, a logical next step. Previously, a 
live attenuated salmonella vaccine platform was used to deliver PlcC, NetB, or both to 
broiler birds. This study found that broilers immunized against both PlcC and NetB had 
fewer severe lesions when challenged with C. perfringens than birds immunized with 
either antigen alone (Jiang et al., 2015). Given these finding an approach combining 
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both the truncated PlcC region of C. perfringens -toxin and a W262A rim mutant of 
NetB via a short, 15 amino acid, linker was perused. A 6-histadine tag was added to the 
fusion protein to allow metal affinity chromatography purification, a process by which a 
cobalt bead is used to capture the 6-histadines via ionic bonds which can be broken in 
downstream elution steps (Karakus et al., 2016). The final fusion protein was dubbed 
PlcC-NetB. 
Plant Based Transient Expression of a Fusion Protein 
Nicotiana benthamiana was selected as the appropriate expression vector for 
many reasons, one of which was salmonella’s inability to produce the fusion protein. 
However, N. benthmiana is a desirable expression vector for a multitude of other 
reasons, including safety, cost effectiveness, and scalability (Diamos et al., 2016; 
Klimyuk et al., 2012). Transient plant expression systems, unlike prokaryotic expression 
systems, allow for complex protein production and protein glycosylation which in turn 
makes the production of monoclonal antibodies and recombinant immune complexes 
(RICs), as well as other proteins requiring eukaryotic post-modification, a possibility 
(Cook et al., 2018; Kim et al., 2015; Mason, 2016; Schähs et al., 2007; Strasser et al., 
2014). Transient plant expression is also optimal compared to transgenic expression as 
large amounts of a desired protein can be produced within 4 days rather than the long 
periods of time required to create a transgenic plant (Huang and Mason, 2004; Kim et 
al., 2015; Marillonnet et al., 2005; Sparkes et al., 2006). 
The use of N. benthmiana is reliant on the natural capability of Agrobacterium 
tumefaciens (Agro) to insert its transfer DNA or T-DNA into plant cells (Marillonnet et 
al., 2005). A. tumefaciens contains a tumor inducing (Ti) plasmid, which encodes all the 
machinery responsible for transduction of a portion of our bean yellow dwarf virus 
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(BeYDV) derived vector plasmid into plant nuclei (Diamos et al., 2016; Diamos and 
Mason, 2018; Huang et al., 2009). The section between the left and right border regions 
is transduced with a the section of the plasmid between a pair of long intergenic regions 
(LIRs) forming a circular plasmid in the plant nucleus which undergoes rolling circle 
replication (Diamos et al., 2016; Diamos and Mason, 2018; Huang et al., 2009; Kim et 
al., 2015). Introduction of an additional LIR allows this geminiviral replication system to 
produce multiple proteins from a single vector, such as antibodies or RICs which encode 
both the heavy and light chains on a singular plasmid (Diamos et al., 2016; Diamos and 
Mason, 2018; Klimyuk et al., 2012; Mason, 2016). Not only are the abilities of the 
geminiviral transient expression system convenient but, due to recent improvements, 
they are currently capable of producing the largest amount of protein known for a 
transient plant expression system (Diamos et al., 2016; Diamos and Mason, 2018). 
The recombinant PlcC-NetB fusion protein was produced using the briefly 
described geminiviral transient expression system above. This lead to the production of a 
large amount of extractable, soluble, and acid stable protein. Once purified via metal 
affinity chromatography the fusion protein was used to immunize broiler birds in three 
separate experiments. Due to concerns of the glycosylated nature of PlcC-NetB which 
was shuttled to the ER, a non-glycosylated (PlcC-NetB-NG) fusion protein targeted to 
the cytosol was also produced. Immunization experiments were also performed for the 
PlcC-NetB-NG fusion protein, however due to protein solubility issues only general 
conclusions about its immunogenicity can be made. Results of broiler bird 
immunizations with ER targeted PlcC-NetB resulted in statistically significant antibody 
titers against PlcC and NetB antigen. Immunization also conferred protection against C. 
perfringens challenge which was determined via lesion scoring of individual birds.  
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METHODS 
Expression Vector Construction. 
Experiments described in this section were performed by Hugh Mason. 
A PlcC-NetB fusion protein was designed and codon optimized for expression in 
N. benthamiana (Geyer et al., 2010). Amino acid sequences were based on GenBank 
accessions AAP15462.1 for PlcC and ABW71134.1 for NetB. Targeting of the fusion 
protein to the ER was facilitated by a barley alpha amylase signal peptide, which was 
followed by the 6-His tag for purification. The signal peptide and 6-His tag were added to 
the N-terminus of PlcC. A polypeptide linker, GGSGGSGGPSGGSGG, was inserted 
between PlcC and NetB (Fig. 1). The gene encoding the complete fusion protein, with 6-
His tag, was synthesized commercially with flanking XbaI and SacI sites. The resulting 
1402 bp XbaI-SacI fragment was ligated with the geminiviral vector pBYR2eK2M 
resulting in the pBYR2eK2M-6H-PlcC-NetB vector (Diamos et al., 2016). Removal of the 
417 bp BamHI fragment, containing the PlcC and linker sequences, yielded ER-targeted 
6H-NetB, pBYR2eK2M-6H-NetB. To construct an ER-targeted 6H-PlcC vector an end-
tailored PlcC sequence was subjected to PCR and a stop codon at a SacI site, at its 3’ end, 
introduced using the primer PlcC-Sac-R: (5’-
CCCGAGCTCCTATTTGATGTTGTAAGTGGAGTTTCC). Inserting the resulting product 
into the pBYR2eK2M vector yielded pBYR2eK2M-6H-PlcC. 
Cytosol-targeted variants of the above ER-targeted constructs were produced by 
removing the signal peptide by introducing an XbaI site and start codon 5’ of the 6-His 
sequence via PCR with primer 6H-Xba-F: (5’ 
GACTCTAGAACAATGGCTCACCATCACCATCATCAC). Resulting XbaI-SacI fragments 
were ligated with pBYR2e3K2Mc-GFP digested with XbaI and SacI, yielding the vectors 
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pBYR2e3K2Mc-c6H-PlcC-NetB, pBYR2e3K2Mc-c6H-PlcC, and pBYR2e3K2Mc-c6H-
NetB (Diamos and Mason, 2018). 
 
Protein Production and Purification 
Expression vectors outlined above were inserted into A. tumefaciens EHA105 via 
electroporation. The transformed agrobacterium was plated on LB + kanamycin (50 
mg/L) plates and individual colonies selected. Resulting colonies were screened using 
PCR and restriction digestion to confirm transformation. Agrobacterium strains were 
grown overnight at 30°C in YENB + 50 mg/L kanamycin and 2.5 mg/L rifampicin. 
Bacteria were pelleted for 10 minutes at 5,000 g, then resuspended in infiltration buffer 
[10 mM 2-(N-morpholino) ethanesulfonic acid (MES), pH 5.5 and 10 mM MgSO4] with a 
final OD600 = 0.2. Needleless infiltration, a process by which a small puncture is made 
in the leaf tissue and a needleless syringe used to force agrobacterium suspensions into 
the leaf, of N. benthamiana leaves at 5- to 6-weeks of age was performed (Huang and 
Mason, 2004). Infiltrated leaves were harvested at 4- to 5-days post infiltration (DPI).  
 
Protein Extraction, Acid Precipitation, and Filtration 
Total protein was extracted from agro-infiltrated leaf samples using a 1:3 (w:v) 
ratio of extraction buffer (50 mM sodium phosphate, 200 mM sodium chloride, pH 8.1) 
at 4˚C with 50 mM sodium ascorbate and 1 mM PMSF added. Using a two speed 
Conair™ Waring™ Laboratory Blender (Fisher Scientific, Waltham, MA) leaf samples 
were homogenized for 5-10 min until an even consistency was obtained. Homogenized 
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leaf tissue was stirred at high speed for 10 minutes at 4°C to improve protein solubility 
before acid precipitation. 
Acid precipitation was performed by adding 1 M phosphoric to the crude extract 
with constant mixing until a pH of 4.4-4.6 was reached, as measured by a VWR Sb70 
Symphony Ph Meter (VWR, Radnor, PA). The acidified extract was stirred for 10 min at 
4°C. After this 10 minute period, 2 M Tris base was added to the extract until a pH of 7.5-
7.7 was reached. The mixture was stirred for another 10 min at 4°C before being filtered 
through Miracloth and centrifuged at 17,000g, 4°C, for 30 min. The extract was then 
subjected to a second filtration through Miracloth resulting in a clarified extract, which 
was passed through a 0.45-micron filter for sterilization before metal affinity 
chromatography. 
 
Metal Affinity Chromatography and Dialysis 
3 mL of Talon metal affinity resin (Clontech/Takara Bio, Mountain View, CA) was 
spun down at 10,000 g, 4°C, for 5 min and the supernatant removed from the bed 
volume. Resulting bed volume (1.5 mL) was washed using 15 mL of extraction buffer 
(referred to below as wash buffer) before being spun down at 10,000 g, 4°C, for 5 min. 
Supernatant was discarded and another 15 mL of wash buffer added to resuspend the 
resin bed volume before it was added to a 20 mL column and washed with an additional 
20 mL wash buffer. Once wash buffer had been passed through the column the clarified, 
filtered extract was added to the column. Once filtered extract was passed through the 
column 60 mL of wash buffer was used to remove any loosely bound protein 
contaminants. Five elutions, each of 1 mL  PBS + 150 mM imidazole, pH 7.4, were added 
to the column and collected individually. 
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 Elution samples were dialyzed overnight in 1 L sterile PBS using either a 3 mL or 
10 mL 3,500 MWCO Slide-A-Lyzer G2 dialysis cassette (Thermo Scientific, Waltham, 
MA), following manufacturer’s instructions. A280 absorption was utilized to determine 
protein concentration of elutions both before or after dialysis, using PBS + 150 mM 
Imidazole and PBS as blanks, respectively. Protein concentrations were confirmed by 
Coomassie staining of SDS-PAGE gels analyzed with ImageJ (Schneider et al.) 
 
SDS-PAGE and Western Blot 
Crude extracts, clarified extracts, and eluted samples were mixed with SDS 
sample buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.02 % bromophenol 
blue) under reducing conditions (0.5 M DTT). Samples were then boiled for 10 min and 
separated on 4-15% polyacrylamide gels (Bio-Rad, Hercules, CA). Gels were stained with 
Coomassie stain (Bio-Rad) or electroblot transferred to a PVDF membrane. PVDF 
membranes were blocked with 5% PBSTM (PBS with 0.05% Tween-20 and 5% nonfat 
dry milk) overnight at 4°C. Membranes were then washed with PBST before incubation 
with a 1:10,000 dilution of rabbit anti-PlcC or rabbit anti-NetB antibodies in 1% PBSTM 
for 1 hour at 37°C (Jiang et al., 2015). After probing with the relevant antibody, 
membranes were washed again before being incubated with a 1:10,000 dilution of goat 
anti-rabbit horseradish peroxidase conjugate in 1% PBSTM. Bound antibody was 
detected with ECL reagent (Amersham).  
Stripping-for-reprobing was performed using a modified Abcam protocol 
(Stripping for reprobing). PVDF membrane was washed for 10 min in mild stripping 
buffer (for 1 liter: 15 g glycine, 1 g SDS, 10 mL Tween20, pH 2.2) per Abcam’s recipe. 
PVDF membrane was then rinsed twice in 20 mL of PBS for 10 minutes followed by two 
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5 min rinse steps in 20 mL PBST. 5% PBSTM was used to block the membrane before re-
probing which followed the above Western blotting steps. 
 
Production of Recombinant Proteins in E. coli for Immune Assays 
 Experiments described in this section were performed by members of the Roland 
lab. 
His-tagged recombinant PlcC (rPlcC) and NetB (rNetB) were cloned by PCR. The 
resulting PCR fragments were digested with BamHI and SalI and ligated to BamHI/SalI-
digested plasmid pQE30. Plasmids carrying the desired inserts were electroporated into 
E. coli strain M15(pREP4) (Qiagen). Protein synthesis was induced by the addition of 
IPTG according to the manufacturer’s instructions. rPlcC and rNetB were purified by 
passage over a TALON affinity column (Clonetech Laboratories, Inc, Mountain View, 
CA) following the manufacturer’s recommendations. 
 
Vaccination of Broiler Birds 
 Experiments described in this section were performed by members of the Roland 
lab. 
Jumbo Cornish X rock chicks were immunized subcutaneously in three separate 
experiments. In experiment 1 birds were immunized with 50 µg of fusion protein and 50 
µg of Quil-A adjuvant. Birds were given three immunizations at weekly intervals 
beginning at 11 days of age, with the final immunization at 25 days of age.  
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In experiment 2 birds were immunized with 100 µg of fusion protein and 50 µg of 
Quil-A adjuvant. Similarly to experiment 1, birds received 3 doses starting on day 11 with 
the final immunization at 25 days of age. For both experiments 1 and 2 blood was taken 
for serum analysis one week after final boost. Three days later, when the birds were 33 
days of age, birds were given an in-feed challenge with virulent C. perfringens for 5 days. 
The birds were scored for intestinal lesions the following day.  
For experiment 3, birds were injected with 50 µg of PlcC-NetB at 7 days of age 
and again at 12 days of age. Blood and tissues were taken for immunological analysis ten 
days after the boost. Birds were challenged two weeks after the final boost, when the 
birds were 26 days of age. 
 
Challenge with C. perfringens 
 Experiments described in this section were performed by members of the Roland 
lab. 
Chickens were fed an antibiotic-free starter feed containing 21% protein for 20 
days, at which time the feed was switched to a high protein (28% protein), wheat-based 
feed containing 36% fish meal and zinc at 400 ppm (customized by Reedy Fork Farm, 
NC) to predispose the birds to NE (Coursodon et al., 2012; Shojadoost et al., 2012). Birds 
were challenged with virulent C. perfringens strain CP4 in feed for 5 days with some 
modifications (Thompson et al., 2006). Feed was withdrawn on the day prior to 
challenge for 15 h. The following day, chickens were orally gavaged with 1.0 mL of an 
overnight culture of C. perfringens CP4 grown in CMM medium. Immediately after 
gavage, infected feed was provided thereafter for 5 consecutive days. To prepare infected 
feed, C. perfringens was grown in CMM medium for 24 h at 37°C, which was then 
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inoculated into FTG medium at a ratio of 0.3% (v/v) and incubated at 37°C for 15 h 
(morning challenge) or 23 h (evening challenge). The C. perfringens culture was mixed 
with feed at a ratio of 1:1 (v/w). Infected feed was prepared fresh twice daily. All birds 
were euthanized and necropsied the day following the final challenge. 
 
Lesion Scoring 
Experiments described in this section were performed by members of the Roland 
lab. 
Protection against C. perfringens challenge was assessed based on gross 
intestinal lesion scores at necropsy. On day 33, birds were euthanized with CO2 and their 
small intestines (defined herein as the section between the gizzard and Meckel’s 
diverticulum) were examined for visible gross lesions. Intestinal lesions were scored as 
follows: 0 = no gross lesions; 1 = thin or friable wall or diffuse superficial but removable 
fibrin; 2 = focal necrosis or ulceration, or non-removable fibrin deposit, 1 to 5 foci; 3 = 
focal necrosis or ulceration, or non-removable fibrin deposit, 6 to 15 foci; 4 = focal 
necrosis or ulceration, or non-removable fibrin deposit, 16 or more foci; 5 = patches of 
necrosis 2 to 3 cm long; 6 = diffuse necrosis typical of field cases (Shojadoost et al., 
2012).  Birds that died during challenge were assigned a score of 6. 
 
Statistical Analysis 
Experiments described in this section were performed by members of the Roland 
lab. 
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All statistics were carried out using GraphPad Prism 6.0 (Graph-Pad Software, 
San Diego, CA). Antibody titers and lesion scores were analyzed using one-way ANOVA 
followed by Tukey’s posttest. The values were expressed as means ± SEM, and 
differences were considered significant at P < 0.05 
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RESULTS 
Construction of a PlcC-NetB Fusion Protein 
 A fusion protein comprising an N-terminal 6-His tag, PlcC, linker, and NetB was 
designed (Fig. 1). The polypeptide linker, GGSGGSGGPSGGSGG, was used to avoid 
steric hindrance, allowing for proper protein folding, and allow ready access to all 
conformational epitopes. The PlcC-NetB fusion protein contains 5 eukaryotic Asn-linked 
glycosylation sites (N-X-S/T), which could result in addition of glycans to the Asn 
residue when the protein is targeted to the ER in plant cells. Expression vectors were 
constructed to target proteins to the ER (pBYR2eK2M-6H-PlcC-NetB, -6H-PlcC, and 
6H-NetB), or to the cytosol (pBYR2e3K2Mc-c6H-PlcC-NetB, -c6H-PlcC, and -c6H-
NetB). It was expected that the cytosol targeted proteins would be unglycosylated while 
the ER targeted proteins would be glycosylated in any combination of, or all, the 5 Asn-
linked glycosylation sites. 
 
 
 
 The fusion protein detailed in Figure 1 was inserted into a geminiviral expression 
vector containing many different and important elements. These elements are outlined 
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in figure 2. The most important of these elements are the LIRs, SIR, C1/C2, and boarder 
regions.  
 
Production of PlcC-NetB and PlcC-NetB-NG Fusion Proteins in Plants 
Using the methods outlined herein two different fusion proteins were produced. 
One, targeted to the endoplasmic reticulum (ER), was glycosylated (PlcC-NetB). The 
other, targeted to the cytoplasm, was non-glycosylated (PlcC-NetB-NG). Both fusion 
proteins were probed with rabbit anti-PlcC and rabbit anti-NetB antibodies which 
detected the same ~49 kDa protein on a western blot (Fig. 3). PlcC-netB also has 
incrementally increased band sizes up to ~63 kDa, with the smallest band aligning with 
the singular PlcC-NetB-NG band at approximately 49 kDa which is the expected relative 
size of the fusion protein (Fig. 3). 
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The process of purification for the PlcC-NetB protein is displayed in Figure 4A. 
Coomassie (Fig. 4A) shows an uninfiltrated, wild-type (WT) control followed by crude 
extract which has already been acid precipitated. Flow through contains bands of a 
similar profile to the crude extract on the Coomassie while both washes have no apparent 
banding. A GST-NetB standard is present followed by three elutions which contain bands 
at approximately 59 kDa. Anti-NetB antibodies (Fig. 4B) reacted with the standard and 
elution 2 primarily, while elution 1 and 3 have visible but less prominent bands. A bell 
curve relationship, where a middle elution has the highest protein concentration, is 
expected from a Talon resin elution protocol and is apparent in PlcC-NetB elutions. 
There is also a very light band present in the crude extract, giving an indication of 
relative concentrations.  
When probed with anti-PlcC antibodies (Fig. 4C) similar bands can be seen in 
every lane except the blank and NetB standard lanes. Elution bands are as strong as 
those seen in the crude extract lane. Flow through and wash lanes have lighter but still 
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present bands when probed with anti-PlcC. Bands which reacted with anti-PlcC 
antibodies are also located at approximately 49 kDa. 
 
 To determine whether or not A280 readings of the eluted and dialyzed protein 
samples were accurate enough to use for protein concentration determination a 
Coomassie gel (Fig. 5B) was run with sequential dilutions (1:1, 1:2, 1:4, 1:8) of both a 2 
mg/mL BSA standard and a single PlcC-NetB-NG elution reading ~2 mg/mL. The 
dilutions of the BSA standard and elution were compared using ImageJ. Figure 5A shows 
the resulting graph which has two almost identical trend lines, with the exception of the 
final dilutions. These trend lines show that the A280 is an accurate estimate of protein 
concentration when acid precipitation and metal affinity chromatography are used in 
conjunction to remove an estimated 95% of native plant proteins.   
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Serum Antibody Responses to Fusion Protein Antigens 
 Serum antibody responses against PlcC-NetB were evaluated using recombinant 
rPlcC and rNetB produced in bacteria as well as the plant made fusion protein. Anti-
PlcC-NetB titers were significantly higher than controls in all experiments (Fig. 6). In 
experiments 1 and 2 titers against rPlcC and rNetB were also elevated and significant 
(Fig. 6A, 6B). In experiment 3, when broiler birds were only immunized twice, at day 7 
and 12, only the titers against the fusion protein were significant (Fig. 6C).  
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Cellular Responses Against PlcC-NetB in Experiment 1 and 3 
 Immunization with PlcC-NetB led to variable cellular responses. The fusion 
protein elicited weak but significant cellular responses against rNetB and rPlcC-NetB in 
splenocytes during experiment 1 (Fig. 7). This was shown again in experiment 3 (Fig. 
8). However, no significant antigen-specific stimulation was detected in lymphocytes 
except for an odd case of PlcC-NetB-NG vaccinated chickens having a response to PlcC. 
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Protection Against C. perfringens Challenge 
 Protection against C. perfringens challenge was assessed by scoring intestinal 
lesions using a six point scoring system (Thompson et al., 2006). Immunization with 
PlcC-NetB and PlcC-NetB-NG resulted in statistically significant reduction in lesion 
scores across all three experiments (Fig. 9). In experiment 3 (Fig. 9C) birds were 
challenged a week earlier than those in experiment 1 (Fig. 9A) and experiment 2 (Fig. 
9B). We speculate that this may have been the cause of the higher lesion scores in some 
birds. Note that two birds died due to challenge during experiment 3 and were thusly 
given a lesion score of 6. These were the only two birds to die from C. perfringens 
challenge. Note that the Y-axis, while aligned, are not the same. Though the amount of 
PlcC-NetB-NG delivered to broiler birds cannot be accurately assessed, the resulting 
protection from challenge was almost identical to the PlcC-NetB fusion protein. We 
speculate that this result tells us that the dose was similar to that of PlcC-NetB. It also 
suggests that the glycosylation of ER-targeted fusion protein does not interfere with 
presentation of protective epitopes of PlcC and NetB.   
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DISCUSSION 
 As nations and companies continue to reduce their reliance on antibiotics for 
protection against diseases such as NE the need for permanent alternatives will rise. 
Vaccination is a proven method for controlling disease and immunization with antigens 
based on toxins has routinely proven effective (Crouch et al., 2010; Keyburn et al., 2013; 
Yan et al., 2013). However, immunizing with both the PlcC -toxid and attenuated NetB 
provides better protection than when either antigen is used alone (Fernandes da Costa et 
al., 2016). Based on these observations, a novel fusion protein combining both PlcC and 
NetB was designed and shown to confer protection through immunization. Using a plant 
based expression system for the production of the PlcC-NetB fusion protein has many 
advantages including, high yields, ease of stockpiling, rapid and easy scaling, quick 
response to emerging pathogens, and lack of any animal components in the final vaccine 
product. 
 Production of a PlcC-NetB fusion protein was readily accomplished in N. 
benthamiana using a geminiviral replicon transient expression system. While other 
expression systems were unable to produce the fusion protein, namely salmonella, the 
plant expression system was shown to do so at a high capacity. High levels of protein 
production, 400 µg purified protein/g fresh leaf weight on average for both glycosylated 
and non-glycosylated fusion protein, were due to our use of the geminiviral replicon 
transient expression system which has been recently optimized and has undergone 
improvement since the production of the PlcC-NetB fusion protein (Cook et al., 2018; 
Diamos et al., 2016; Diamos and Mason, 2018). Due to these recent improvements our 
bean yellow dwarf virus geminiviral replicon transient expression system is now able to 
outproduce leading industry expression systems (Diamos et al., 2016; Diamos and 
Mason, 2018; Mason et al., 2014). 
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 Acid precipitation (a process by which the isoelectric point of proteins, and their 
repulsive electrostatic forces, equal zero and results in protein aggregation) proved to be 
an effective clarification step, over other purification methods, as both the PlcC-NetB 
and PlcC-NetB-NG fusion proteins proved to be acid stable (Wilken et al.). This allowed 
for easy purification using metal affinity chromatography as the majority of plant protein 
contaminants were removed from solution while the fusion proteins remained soluble. 
While the metal affinity chromatography did purify the protein to a substantial degree, 
contaminants could be seen upon concentration of elutions (data not shown). However, 
contaminants were deemed not to be an issue for vaccination as they were in 
concentrations estimated to be 5-10%. 
Since a plant expression system was used, native plant glycosylation of the ER-
targeted fusion protein PlcC-NetB occurred. An illustration of this can be seen in both 
Figure 3 and Figure 4 as there are progressively higher bands above the lowest fusion 
protein band at 49 kDa only in the ER targeted variant. Glycosylation was a concern as 
an immune response could potentially be directed towards the glycans rather than the 
fusion protein itself (Maverakis et al., 2015; Schähs et al., 2007; Strasser et al., 2014), or 
the glycans could mask native protein epitopes. For this reason, a PlcC-NetB-NG fusion 
was pursued.  
PlcC-NetB-NG proved to be troublesome as it precipitated after dialysis in 4˚C, a 
phenomenon that has been observed for rubisco, the most abundant plant protein 
contaminant. This may indicate that the glycoforms play a role in protein stability and 
solubility as PlcC-NetB did not have solubility issues under the same buffer, 
concentration, and purification conditions. It is also possible that the plant contaminants 
became insoluble and protein interactions between PlcC-NetB-NG and native plant 
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proteins lead to the non-glycosylated fusion protein becoming insoluble as well. PlcC-
NetB Results indicate that, even with plant native glycosylation, the PlcC-NetB fusion 
promoted an anti-toxoid response. We speculate that the glycoforms could have possibly 
had an adjuvant effect as antibody titers for the fusion protein were greater than E. coli 
produced PlcC and NetB delivered simultaneously (Bosch and Schots, 2010). In any case, 
production of both the PlcC-NetB and PlcC-NetB-NG fusion proteins was found to be 
efficient on a small scale. Due to the nature of plant based transient expression systems, 
this process is readily scalable. Moreover, the fusion protein vaccine was found to be 
effective when injected into broiler birds as is discussed below.  
In Experiments 1 and 2, three weekly injections with the fusion protein generated 
strong serum IgY responses (Fig. 6). Vaccinated birds had geometric mean titers of 
around 2,000 against recombinant NetB and PlcC proteins purified from E. coli (Fig. 6). 
Titers against the PlcC-NetB fusion protein produced in plants were around 8,000 in 
immunized birds. The difference in titers between single proteins and the fusion protein 
is speculated to be due to enhanced immune response to the fused protein, since PlcC 
and NetB are both present during infection, or responses against the carbohydrate 
moieties on the glycosylated protein leading to an enhanced immune response. 
PlcC-NetB and PlcC-NetB-NG vaccination led to variable lymphocyte and 
splenocyte responses when tested with recombinant PlcC and NetB. The fusion protein 
elicited relatively weak responses in splenocytes (Fig. 7). This was seen in experiment 3 
as well, for chickens vaccinated with either the glycosylated and non-glycosylated fusion 
protein (Fig. 8). However, no significant antigen-specific stimulation was detected in 
lymphocytes in experiment 3 except for PlcC in broilers that were vaccinated with an 
unknown amount of PlcC-NetB-NG (Fig. 8). This is an odd outlier and it is concerning 
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that no other antigen elicited a response as PlcC did. Background was also seen to be 
high in all these experiments. This may be explained by C. perfringens being native to 
the gut microbiome of chickens. We speculate that some amount of antibodies/immune 
cell recognition may always occur due to this fact. All broilers, across all experiments, 
when vaccinated with either PlcC-NetB or PlcC-NetB-NG did exhibit vaccination 
mediated protection from C. perfringens challenge (Fig. 9). 
In Experiment 3 birds were immunized at 7 and 12 days of age. We speculate that 
this lead to a reduced immune response as the chicken adaptive immune system does not 
fully mature until approximately two weeks post-hatch, although humoral responses can 
be detected after immunization with a protein antigen at 12 days of age (Mast et al.). It 
has been shown that an adjuvanted NetB toxoid was ineffective when injected into day-
of-hatch chicks (Mot et al., 2013). Therefore, it is possible that immunization at day 7 
was ineffective and the immunization at day 12 was effectively the priming dose. It has 
been shown that immunization at 12 days of age, but not 7 days of age, can be boosted by 
injection at 29 days of age (Mast et al.). Even though the chickens were effectively not 
boosted, we infer that the birds were adequately primed since, despite the low serum 
antibody responses, they were protected against challenge (Fig. 9C). 
We have demonstrated that this novel fusion protein produced in plants is not 
only efficient to produce but immunogenic and protective in chickens. However, we 
acknowledge that a more practical immunization approach is needed in order to have a 
positive impact on the broiler industry. There are several options for immunization on an 
industrial scale that will not only protect chickens, but will also promote farmer 
compliance. Immunization of parent stock is likely to induce maternal antibodies to 
protect chicks during the first few weeks of life. This approach has been demonstrated to 
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be effective with an -toxoid (Crouch et al., 2010). However, maternal antibodies are no 
longer circulating en mass by 2-4 weeks post hatch. Alternatively, protein antigens can 
be successfully delivered via in ovo injection with an adequate adjuvant. Delivery of the 
fusion protein via cornmeal could also be a cheap and effective mass delivery method for 
vaccine produced in corn seeds. The effectiveness of these approaches will be assessed in 
future studies. 
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FUTURE WORK 
 The first step in continuing the PlcC-NetB project would be to solve the issue of 
PlcC-NetB-NG solubility. While it has been hypothesized that the insolubility issue of the 
non-glycosylated protein could be due to its lack of glycans, paired with plant protein 
contaminants having an aggregating effect, it is worth pursuing due to greater protein 
volume per leaf gram produced than the glycosylated variant. One simple option would 
be to purify as has already been outlined and simply dialyze/store at 16˚C - 25˚C. 
However, this may become an issue if protein stability is suboptimal at temperatures 
above 4˚C or if the PlcC-NetB-NG aggregates at these temperatures in the presence of 
plant proteins as well.  
 An additional cause of the insolubility of PlcC-NetB-NG may be stripping of 
metal ions from both PlcC and NetB that are normally present. According to the crystal 
structure of PlcC it likely binds calcium though due to difficulties in creating the crystal 
structure cadmium was substituted (Naylor et al., 1998). NetB has been shown to bind 
magnesium in its crystal structure (Yan et al., 2013). These metal ions could be removed 
during the final dialysis step, which might affect protein structure and solubility. These 
ions could also be removed at another step in the purification process. Therefore, adding 
Ca2+ and Mg2+ in sub-mM concentrations to all steps may solve the issue of solubility.  
 Another option is using an additional purification method similar to those used 
industrially to both remove all protein contaminants and test the feasibility of the 
selected technique. Purification techniques include two dimensional gel electrophoresis, 
size exclusion chromatography, ion exchange chromatography, or immunoaffinity 
chromatography which would utilize the already present 6-His tag (Gräslund et al., 
2008). Any of these techniques could be applied to a small-scale purification and are 
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used, on one scale or another, industrially. While testing for the optimal large scale 
purification technique is important, performing a purification is key to discovering if the 
PlcC-NetB-NG fusion protein is becoming insoluble due to plant protein contaminants or 
due to self-interactions and aggregation.   
 While discovering the reason for PlcC-NetB-NG insolubility is important, using 
an isolated protein may not be the best option for vaccination. While this would be 
needed for in-ovo vaccination, and perhaps for maternal vaccination, targeting the PlcC-
NetB fusion protein to seeds, namely from corn, could be the optimal approach for wide 
spread broiler bird vaccination. It has been shown that the use of the zein signal peptide 
routinely shuttles a target protein to protein bodies in N. benthamiana (Conley et al., 
2011; Hofbauer et al., 2016). Zein signal peptides have also been shown to shuttle 
proteins to corn seeds where large amounts of the zein protein are generally directed 
(Nuccio, 2018). Since milled corn is regularly used to feed broiler birds it would be 
simple to supplement their diets with corn that contains PlcC-NetB. There are some 
drawbacks to this approach, the main being the use of transgenic corn rather than 
performing transient expression in N. benthamiana. Creation of transgenic plants 
requires a substantial amount of time and resource investment. Small scale experiments 
of this type therefore pose a bigger investment risk. That being said, there are many risks 
this approach avoids including: expensive industrial purification, farmer compliance 
issues, vaccine coverage, and ease of vaccine administration.  
 However, in ovo vaccination could also avoid most of the issues already 
mentioned with the exclusion of industrial protein purification. If in ovo vaccination is 
shown to work, the companies who hatch the chicks before they are shipped to farms 
could perform the vaccination easily. This would remove farmer compliance and vaccine 
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coverage issues completely. The main downside is the upfront investment for equipment, 
which is avoided in the corn-based delivery method, and cost of purifying the fusion 
protein. 
 Finally, additional research should be performed to optimize the time course of 
vaccine administration in any form as well as the optimal amount of antigen to be 
delivered. Further work should also be done to determine whether or not glycosylation of 
the PlcC-NetB fusion lead to higher antibody titers and greater protection against 
challenge. This is simple enough to perform in conjunction with testing the solubility of 
PlcC-NetB-NG if the non-glycosylated protein can be routinely purified while retaining 
solubility. If protein using zein as a signal peptide is produced its solubility and 
immunogenicity must also be tested in similar studies as those performed in this study.  
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